Moderna, Inc. Modification Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. PZ00013 to Contract W911QY20C0100 between Moderna US, Inc. and U.S. Army for COVID-19 Response
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. P00024 to Contract W911QY20C0100 between the U.S. Government and Moderna US, Inc. for COVID-19 Vaccine Storage and Distribution Extension
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. P00013 to Contract No. 75A50120C00034 between ASPR-BARDA and ModernaTX, Inc.
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment to U.S. Department of Defense Contract with Moderna US, Inc. for Pediatric COVID-19 Vaccine Supply (Contract No. W911QY20C0100, Modification P00022)
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment to BARDA Contract No. 75A50120C00034 with ModernaTX, Inc. for Expanded Clinical Studies Funding
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. P00018 to Contract W911QY20C0100 between U.S. Department of Defense and Moderna US, Inc.
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. P00011 to Contract No. 75A50120C00034 between US Department of Health & Human Services and ModernaTX, Inc.
Modification Agreements
Moderna, Inc.
Biotechnology
2022
Amendment No. 10 to Contract #75A50120C00034 Between ASPR-BARDA and ModernaTX, Inc. for COVID-19 Vaccine Development
Modification Agreements
Moderna, Inc.
Biotechnology
2021
Amendment to U.S. Government Contract with Moderna US, Inc. (Contract No. W911QY20C0100) – Modifications P00012 and P00013
Modification Agreements
Moderna, Inc.
Biotechnology
2021
Amendment No. 7 to Contract 75A50120C00034 Between ModernaTX, Inc. and U.S. Department of Health & Human Services for mRNA-1273 Vaccine Development
Modification Agreements
Moderna, Inc.
Biotechnology
2021
Amendment No. 6 to Contract 75A50120C00034 Between ModernaTX, Inc. and U.S. Department of Health & Human Services (BARDA)
Modification Agreements
Moderna, Inc.
Biotechnology
2021